NL-OMON34174CompletedNot Applicable
Efficacy of MT204 in a humanized mouse model of psoriasis - Module 2 - - Pre-clinical efficacy of MT204 in psoriasis
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Micromet AG
- Enrollment
- 24
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Psoriasis patients: Adults (m/f) with a mild form of psoriasis vulgaris (PASI score of maximal 6). Patients are allowed to use local corticosteroids or ointments to prevent dry skin (see Appendix 2).
Exclusion Criteria
- •Psoriasis patients: These patients have not received light therapy or another form of systemic treatment (methotrexate, cyclosporin A, anti-TNF treatments). Gender or age of the adults are not exclusion criteria (see Appendix 2).
Investigators
Similar Trials
Completed
Not Applicable
Efficacy of a novel compound in a humanized mouse model of psoriasisflaking diseasepsoriasis1000381610014982NL-OMON35253TNO29
Completed
Not Applicable
Efficacy of a novel compound in a humanized mouse model of psoriasisNL-OMON36840TNO24
Not yet recruiting
Not Applicable
Efficacy of a novel compound in a humanized mouse model of psoriasisflaking diseasepsoriasis1000381610014982NL-OMON37700TNO25
Completed
Not Applicable
Development and validation of a humanized mouse psoriasis model to be applied for efficacy analysis of novel therapeutic compoundsFlaking diseasePsoriasis10014982NL-OMON41218TNO Triskelion6
Not yet recruiting
Not Applicable
Clinical research on a neuroprotective effect of minocycline treatment in the acute stage of Ischemic StrokeJPRN-UMIN000002332Takeshi Takahashi200